Alcohol consumption leads to the production of the highly reactive ethanol metabolite, acetaldehyde, which may affect intestinal tight junctions and increase paracellular permeability. We examined the effects of elevated acetaldehyde within the gastrointestinal tract on the permeability and bioavailability of hydrophilic markers and drug molecules of variable molecular weight and geometry. In vitro permeability was measured unidirectionally in Caco-2 and MDCKII cell models in the presence of acetaldehyde, ethanol, or disulfiram, an aldehyde dehydrogenase inhibitor, which causes acetaldehyde formation when coadministered with ethanol in vivo. Acetaldehyde significantly lowered transepithelial resistance in cell monolayers and increased permeability of the low-molecular-weight markers, mannitol and sucrose; however, permeability of high-molecular-weight markers, polyethylene glycol and inulin, was not affected. In vivo permeability was assessed in male SpragueDawley rats treated for 6 days with ethanol, disulfiram, or saline alone or in combination. Bioavailability of naproxen was not affected by any treatment, whereas that of paclitaxel was increased upon acetaldehyde exposure. Although disulfiram has been shown to inhibit multidrug resistance-1 P-glycoprotein (P-gp) in vitro, our data demonstrate that the known P-gp substrate paclitaxel is not affected by coadministration of disulfiram. In conclusion, we demonstrate that acetaldehyde significantly modulates tight junctions and paracellular permeability in vitro as well as the oral bioavailability of low-molecular-weight hydrophilic probes and therapeutic molecules in vivo even when these molecules are substrates for efflux transporters. These studies emphasize the significance of ethanol metabolism and drug interactions outside of the liver.
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The metabolism of ethanol leads to the production of acetaldehyde, a highly promiscuous intermediate, that is able to react with various proteins and results in the formation of adducts at concentrations as low as 5 M (Salmela et al., 1997) . Lysine is the major amino acid residue that is associated with adduct formation (Tuma et al., 1987) via an intermediary Schiff's base (Braun et al., 1995) . Proteins that preferentially form adducts with acetaldehyde include hemoglobin, albumin, tubulin, lipoproteins, collagen, and CYP2E1 (Niemelä , 1999) . Although the rate of protein adduct formation remains unclear, the number of nucleophilic amino acid residues (e.g., Lys and Cys) within the protein apparently increases total adduct formation (Mauch et al., 1986) .
Upon the administration of ethanol, high concentrations of acetaldehyde can be measured in blood. In rats, peak blood acetaldehyde concentrations are in the millimolar range (Kinoshita et al., 1996) ; in human blood, after ethanol consumption, concentrations have been measured in the micromolar range (Nuutinen et al., 1983) , and it should be noted that this range is considered pathophysiologically relevant (Atkinson and Rao, 2001 ). It has also been estimated that 30 M free, unreacted, nonadduct acetaldehyde circulates in the blood of heavy drinkers (Brecher et al., 1997) .
Emerging evidence suggests that pathophysiologically relevant concentrations of acetaldehyde are also found in the stomach and upper gastrointestinal (GI) tract. Various alcohol dehydrogenase (ADH) isoenzymes (I-IV) occur at different levels along the GI tract of the rat (Julià et al., 1987; Vaglenova et al., 2003) . Although ADH IV predominates on the epithelial surface of the esophagus and stomach, only ADH I is found in the duodenum (Vaglenova et al., 2003) . Upon increasing levels of ethanol consumption, ADH I in the gut becomes saturated and it has been observed that CYP2E1 is induced in both stomach and small intestine to levels 25% above levels in controls (Pronko et al., 2002) . Although ADH metabolism of ethanol in the GI tract is comparatively lower than that in the liver, it may still contribute significantly to local concentrations of acetaldehyde in the upper GI tract (Pronko et al., 2002) .
In concert with adherens junctions, tight junctions and their associated actin filaments compose the apical junctional complex between epithelial cells of the small intestine. The loosening of this complex and the formation of the "leaky gut" in chronic alcoholics has received substantial research interest (Atkinson and Rao, 2001; Keshavarzian et al., 2001; Basuroy et al., 2005) . Studies demonstrate that acetaldehyde increases tyrosine phosphorylation via modulation of tyrosine kinases or protein tyrosine phosphatases in three tight junctional proteins, ZO-1, E-cadherin, and ␤-catenin, which may be responsible for increased membrane permeability (Atkinson and Rao, 2001 ). In the lower GI tract, anaerobic bacteria express ADH and have the ability to metabolize ethanol and produce acetaldehyde (Rao, 1998) . In both humans and rats, colon acetaldehyde levels may achieve millimolar concentrations (Koivisto and Salaspuro, 1997; Rao, 1998; Atkinson and Rao, 2001) . This is an important fact, as endotoxin is suspected to enter the bloodstream via "leaky" tight junctions and play a role in alcohol-induced liver damage (Keshavarzian et al., 1999) .
The concentration of acetaldehyde in the upper GI tract becomes significant because this area represents the site of absorption for most clinically therapeutic drugs. Higher paracellular permeability due to disrupted tight junctions may result in highly variable oral bioavailability; this result is especially problematic for drugs with narrow therapeutic windows. It has been reported that acetaldehyde formation in the intestine is proportional to the ethanol concentration delivered (Koivisto and Salaspuro, 1997) . We hypothesize that the levels of acetaldehyde in the upper small intestine are sufficient to disturb tight junctional organization, thereby affecting drug absorption. In this study, we examined changes in paracellular permeability in epithelial cell culture models and in a rat model of acetaldehyde formation. By using hydrophilic markers and drug molecules of variable molecular weight and geometry, we demonstrate that ethanol metabolism can significantly affect drug absorption and disposition.
Materials and Methods
Chemicals and Reagents. Dulbecco's modified Eagle's medium, phosphate-buffered saline (PBS), nonessential amino acids, sodium pyruvate, penicillin, streptomycin, L-glutamine, and trypsin/EDTA were purchased from Invitrogen (Grand Island, NY). Fetal bovine serum (0.1 M filtered) was purchased from Gemini Bio-Products (Woodland, CA). Transwell plates of 12-mm diameter (surface area 1.13 cm 2 ) and 0.4 M pore size were purchased from Corning Costar (Cambridge, MA Cell Culture. Human colon adenocarcinoma (Caco-2) cells and Madin-Darby canine kidney (MDCKII) cells were purchased from the American Type Culture Collection (Manassas, VA). Caco-2 cells were used from passage 25 to 45, and MDCKII cells were used from passage 25 to 35 in an effort to derive monolayers with consistent morphological and biological features. All cells were maintained in 75-cm 2 tissue culture flasks at 37°C, in a humidified atmosphere of 5% CO 2 and were cultured in high-glucose Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, 0.1 mM nonessential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 g/ml streptomycin. Cells were passaged to 80% confluence and were released by trypsinization (0.25% trypsin and 0.25% EDTA). MDCKII and Caco-2 cells for use in this study were plated at a seeding density of 50,000 and 80,000 cells/cm 2 , respectively; in 12-well tissue culture-treated Transwell plates. Cell medium was changed every other day, and experiments were performed upon confluence in MDCKII cells (5 days) and upon differentiation in Caco-2 cells (25 days). At this time each monolayer is expected to have polarized, with well developed apical brush borders and tight junctions. Monolayer integrity was assessed by the transepithelial resistance (TEER) value as described in the next section.
Measurement of TEER. TEER of confluent monolayers was measured as an indicator of monolayer integrity as described previously (Hidalgo et al., 1989) , using a Millicell-ERS ohmmeter (Millipore Corporation, Billerica, MA). TEER was calculated as ohms ⅐ per square centimeter by multiplying it by the surface area of the insert (1.13 cm 2 ) and subtracting the internal resistance of the insert before calculations (25 ⍀ ⅐ cm 2 ). TEER was measured at 0, 60, 120, 180, 240, and 300 min. Baseline TEER values for Caco-2 and MDCKII monolayers were between 450 and 600 and 200 and 250 ⍀ ⅐ cm 2 . In Vitro Paracellular Permeability Measurements. The transport of radiolabeled paracellular markers was measured in cells seeded onto Transwell plates in the presence or absence of ethanol (20% v/v), acetaldehyde (1 mM), or disulfiram (25 mg/ml). The markers ranged in molecular weight from mannitol (182.2) to sucrose (342.3), to PEG (4000) to inulin (5000). Caco-2 cells were used at day 25 and MDCKII cells at day 5 and upon confluence were washed twice in PBS. To assess effects on permeability, transport of markers was measured from apical to basolateral chambers at 60, 120, 180, and 240 min (n ϭ 6). Cell treatments were agitated orbitally at no greater than 50 rpm and were performed in sealed airtight containers at 37°C to prevent evaporation and in the study with acetaldehyde were replaced each hour. Radioactivity was measured using scintillation counting. Apparent permeability (P app ) was calculated as
( 1) where ⌬Q/⌬t is the linear appearance rate of mass in receiver solution in the lateral chamber, A is the cross-sectional area of the Transwell plate, and C (0) is the initial concentration of the marker in the apical chamber. Animals. Adult male Sprague-Dawley rats (250 -280 g) were used in the pharmacokinetic measurement of permeability markers. They were purchased from Harlan (Indianapolis, IN). The study protocols were approved by the Institutional Animal Care and Use Committee of the School of Pharmacy (University of Maryland, Baltimore, MD). Rats were housed in the animal facility at a room temperature of 23 Ϯ 1°C. Food was withheld 4 h before oral dosing, and rats were allowed free access to food after dosing (Purina 5001 Rodent Chow; Purina, St. Louis, MO). Water was given ad libitum, and rats were maintained on a 12-h light/dark cycle (light on from 7:00 AM to 7:00 PM).
Ethanol Dosing and In Vivo Permeability Measurements. Rats in each group (n ϭ 5) were treated with saline, disulfiram (100 mg/kg), ethanol (5 g/kg b.wt. given as a 33% v/v solution in saline, approximately 7 M), or ethanol and disulfiram [5 g/kg b.wt. (7 M) and 100 mg/kg (84 M), respectively]. Treatments were administered twice daily via oral gavage for a period of 6 days. On day 5, all animals were anesthetized and underwent jugular vein cannulation. jpet.aspetjournals.org taxel were given via oral gavage to each group. Serial blood samples were taken at 0, 20, 40, 60, 90, 120, 240, 480, 720 , and 1440 min after dosing. Blood was centrifuged (10,000g for 10 min) immediately, and plasma was obtained. Scintillation cocktail was added, and plasma samples were analyzed for radioactivity by an LS 6500 multipurpose scintillation counter (Beckman Coulter, Fullerton, CA). Noncompartmental pharmacokinetic analysis was performed to determine the radiomarker absorption in each treatment group using WinNonlin version 3.1 (Pharsight, Mountain View, CA). Statistical Analysis. All samples in all experiments were analyzed for statistically significant differences between groups using single-factor analysis of variance (ANOVA) with the ␣ value set a priori at p Ͻ 0.05. In vitro and in vivo values are expressed as the mean Ϯ S.E.M. obtained from six experiments (in vitro) or five samples (in vivo).
Results

Reversibility of Transepithelial Electrical Resistance upon Ethanol and Acetaldehyde Treatment.
TEER measurement is a method used frequently to assess the integrity of Caco-2 cell monolayers (Hidalgo et al., 1989; Swaan et al., 1997; Cox et al., 2002; Salama et al., 2003 Salama et al., , 2004 . TEER was measured each hour over the course of the experiment (5 h). Treatment of Caco-2 cell monolayers with both ethanol (20% v/v) and acetaldehyde (1 mM) significantly lowered TEER values from 1 to 4 h (Fig. 1A) ; however, the effect of acetaldehyde was more pronounced. The decrease in TEER values for ethanol and acetaldehyde treatment in MDCKII cell lines paralleled those observed in Caco-2 cells (Fig. 1B) . The maximal decrease in TEER was observed upon acetaldehyde treatment at 240 min and was 73.5 Ϯ 2.5% in Caco-2 cells and 49.6 Ϯ 3.0% in MDCKII cells (Fig. 1) , returning to starting TEER values 60 min after withdrawal of treatment. This reversibility suggests that the opening of tight junctions is not due to cellular cytotoxicity. These results are consistent with our previous data showing that the doses of ethanol and acetaldehyde used here are not cytotoxic (Fisher et al., 2008) .
Ethanol and Acetaldehyde Increase Permeability of Paracellular Markers in Caco-2 and MDCKII Cell Models. To assess the degree of tight junctional opening, various hydrophilic markers of paracellular permeability of increasing molecular weight were used in the Caco-2 cell monolayer. (Fig. 2B) . Compared with ethanol and disulfiram, acetaldehyde treatment resulted in the most pronounced increase in P app for three of the four permeability markers as well as higher overall transport of [ 3 H]mannitol in both cell lines (Fig. 2, C and F) . Mannitol flux values were generally higher and more variable (0.1-2.0 ϫ 10 Ϫ6 cm 2 /s) in the present study than in other reports (Volpe, 2008) and cannot be explained by low radiopurity of the tritiated mannitol probe. A variety of issues (Volpe, 2008 ) may have contributed to this anomaly, but these factors do not necessarily negate the significance of our data when control and treated cell monolayers are compared (Fig. 2) . It is interesting to note that the apparent permeability for the high-molecularweight marker inulin was significantly increased upon alcohol treatment in Caco-2 cells (Fig. 2B ) and acetaldehyde treatment in both cell lines (Fig. 2, C and F ), whereas the P app of PEG-4000 was unaffected by any treatment modality. It should be noted that permeability values of the sucrose are somewhat higher in Caco-2 cells than in MDCKII cells (Fig.  2 , A-C, versus D-F, respectively). This result could be attributed to the presence, albeit at low expression levels, of sucrase in Caco-2 but not MDCKII cell lines (Beaulieu and Quaroni, 1991 Thorens, 2001; Wood and Trayhurn, 2003; Cheeseman, 2008) , potentially resulting in higher apparent permeability measurements for sucrose.
Acetaldehyde Effects on Paracellular Permeability Markers In Vivo. In vitro studies in both Caco-2 and MDCKII cells suggest that low-molecular-weight markers have significantly increased permeability upon treatment with acetaldehyde. Based on these results, the bioavailability Fig. 1 . Effect of control (PBS, छ), disulfiram (25 mg/ml, F), ethanol (20%, f), and acetaldehyde (1 mM, OE) on TEER measured in Caco-2 (A) and MDCKII (B) cell monolayers. TEER was measured from 0 to 300 min. Treatments were removed at 240 min, and cells were allowed to recover in media for 60 min. Each data point represents the mean Ϯ S.E.M. of at least eight experiments. Samples were analyzed for any statistically significant differences between groups using single-factor ANOVA. ‫,ء‬ statistically significant difference between treatment and control, p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.001. upon oral administration of various molecular weight markers were examined in the rat. The four markers were used, as described above, in rats treated with ethanol, disulfiram, or a combination of the two to generate in vivo acetaldehyde. Our laboratory has previously examined the generation of acetaldehyde in the rat in vivo and found that the dosing scheme described under Materials and Methods yields approximately 80 M acetaldehyde in plasma (Fisher et al., 2008) . The percentage of the overall dose of [ 3 H]mannitol detected in plasma was significantly higher in rats treated with ethanol/ 
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at ASPET Journals on July 12, 2017 jpet.aspetjournals.org disulfiram than in rats treated with ethanol alone or disulfiram alone or control rats. We found similar results with rats who received [ 14 C]sucrose and detected a significant increase in systemic sucrose availability only in rats generating in vivo acetaldehyde (Fig. 3B) . The systemic availability of the high-molecular-weight markers, [
14 C]PEG-4000 and [
3 H]inulin, was unchanged compared with that in control rats for any treatment group (Fig. 3, C and D) .
Pharmacokinetic analysis for the [ 3 H]mannitol group demonstrated that the area under the curve (AUC) profile of the acetaldehyde-generating group was approximately 15-fold greater than that of control rats (45,434 Ϯ 5823 Ci ⅐ min/ml versus 3134 Ϯ 642 Ci ⅐ min/ml, respectively). Analysis of the [ 14 C]sucrose group showed an approximate 7-fold increase in the AUC of the marker with values of 290.2 Ϯ 74.7 Ci ⅐ min/ml for the treatment group versus 41.4 Ϯ 7.3 Ci ⅐ min/ml for the control group. These data suggest that in vivo bioavailability is increased in the acetaldehyde-generating rat model in a size-dependent fashion, probably as a result of increased intestinal permeability via pharmacologically induced opening of the tight junctions.
Acetaldehyde Affects on Paclitaxel but Not Naproxen Bioavailability. To further define the potential in vivo relevance of ethanol metabolism in the GI tract of the rat, we studied the effect of acetaldehyde production on the systemic availability of a highly bioavailable drug, naproxen, and a drug with limited bioavailability, paclitaxel. Upon oral dosing with [
14 C]naproxen, there was no significant difference in detected plasma levels in any treatment group (Fig. 5A) . However, there was a significant effect (p Ͻ 0.05) of acetaldehyde production on the bioavailability of paclitaxel (Fig.  5B) , with an approximate 4-fold increase in AUC (7051 versus 1875 mg/ml ⅐ min versus control rats). Although the overall bioavailability of paclitaxel remained very low (less than 6% of the total dose administered) in every treatment group, this result is significant. All of other treatment groups showed no significant influence on paclitaxel bioavailability.
Discussion
The effect of acetaldehyde, which is generated during the course of alcohol consumption, on paracellular permeability and loosening of tight junctions has received increasing attention in recent years (Rao, 1998; Atkinson and Rao, 2001; Seth et al., 2004; Sheth et al., 2004; Basuroy et al., 2005) . These studies have demonstrated a pronounced effect of acetaldehyde on the structure of the tight junction, but the extent of tight junctional modulation and its consequent impact on drug permeability have not been investigated. Therefore, the aim of the present study was to examine the effects (5000) (D) . Rats were treated for 6 days via an oral bolus dose with saline control (छ), 5 g/kg ethanol (Ⅺ), 100 mg/kg disulfiram (E), or 5 g/kg ethanol and 100 mg/kg disulfiram (OE). Uptake of markers was measured using liquid scintillation as a percentage of the total starting dose. Each data point represents the mean Ϯ S.E.M. of at least six experiments from time 0 to 1440 min. Samples were analyzed for any statistically significant differences between groups using single-factor ANOVA. ‫,ء‬ statistically significant difference between treatment group V max and control V max (p Ͻ 0.05). of acetaldehyde produced from ethanol metabolism in vivo on the degree of tight junctional disruption by assessing the permeability of various marker molecules of increasing molecular weight and geometry. In addition, we established the effects of ethanol, its major metabolite, and drugs used to generate in vivo acetaldehyde on the permeability of marker molecules in cell culture models in vitro. To validate the clinical significance of these findings, we determined the effects of ethanol metabolism in the GI tract on the bioavailability of two drug molecules representing different biopharmaceutics classification system (BCS) classes. Naproxen, an over-the-counter nonsteroidal anti-inflammatory drug is a BCS class I/II compound, displaying high permeability and high/low solubility dependent on pH (Wu and Benet, 2005) ; paclitaxel, on the other hand, is a representative of compounds in the relatively rare BCS class IV, which feature poor permeability and solubility characteristics.
Cell lines such as Caco-2 and MDCKII form tight junctions upon differentiation, with apical and basolateral membrane, and are generally considered to be good models for the in vitro study of epithelial permeability. In this study we examined the effects of ethanol (20% v/v), disulfiram (25 mg/ml), and acetaldehyde (1 mM) on the reversibility of TEER in both Caco-2 (Fig. 1A ) and MDCKII cells (Fig. 1B) . TEER is an established measure of the integrity of cellular monolayers and represents a qualitative assessment of the paracellular pathway aperture. As anticipated, disulfiram administration did not affect TEER values because this compound is not known to affect tight junctions or function as a membrane permeabilizer (Balakirev and Zimmer, 2001) . Our data show a significant decrease in cell monolayer TEER values upon treatment with a "sublethal" dose of ethanol (20% v/v). These data are consistent with studies by Ma et al. (1995 Ma et al. ( , 1999 , who showed that ethanol permeabilizes the membrane at concentrations less than 10% (v/v); furthermore, they speculated that ethanol reversibly affects tight junctional function via disassembly of perijunctional actin and myosin filaments. However, the definitive mechanism(s) behind these observed effects remain to be studied. Under the experimental conditions applied here, acetaldehyde reversibly and significantly decreases TEER values, a result that is comparable to those of studies by our laboratory (Fisher et al., 2008) as well as by other groups (Atkinson and Rao, 2001; Basuroy et al., 2005) . Our previous studies showed that acetaldehyde in concentrations up to 2 mM are not significantly cytotoxic (Fisher et al., 2008) . The effect of acetaldehyde on monolayer resistance was more pronounced in MDCKII cell monolayers than in Caco-2 cells (75% versus 50% of their starting values, respectively). Because MDCKII cell and Caco-2 cells originate from the kidney and the intestine, respectively, these data may highlight the differential effect of ethanol and its metabolites on paracellular integrity in different organs.
To further assess the effect of acetaldehyde on membrane permeability, we used several molecular markers of various sizes that cross membranes exclusively via a paracellular route. The permeability of these probes was tested on cell monolayers with fully differentiated cells and junctional complexes. Studies by Knipp et al. (1997) , using a series of structurally unrelated compounds with variable hydrodynamic radii (r h ) estimated the pore radius of Caco-2 cells to be approximately 5.2 Å, whereas Watson et al. (2001) accurately established this pore radius at 4.5 Å using permeability assessment of PEG probes with radii of 3.5 to 7.4 Å. Parallel to TEER data (Fig. 1) , disulfiram had no effect on paracellular permeability of any marker molecules across Caco-2 or MDCKII cell monolayers (Fig. 2, A and D) , whereas ethanol increased mannitol (r h ϭ 4.1 Å) but not sucrose (r h ϭ 5.2 Å) permeability (Fig. 2, B and E). Acetaldehyde treatment (Fig.  2, C and F) effected the greatest permeability increase for both mannitol and sucrose. MDCKII cells showed a significant increase in marker permeability only with acetaldehyde treatment, which was somewhat unexpected based on the significant decrease in TEER values observed above (Fig. 1) . This result suggests that ethanol and acetaldehyde have different mechanisms of paracellular permeability enhancement in MDCKII cells. It is interesting to note that Caco-2 cell monolayers displayed a significant permeability increase of the high-molecular-weight marker, inulin (5000), but not PEG-4000 (4000). This result may be explained by the compact spherical shape of inulin (r h ϭ 10 Å versus 15.9 Å for PEG-4000), which makes it more amenable to paracellular transport. This effect was observed previously by Ghandehari et al. (1997) , who demonstrated that the permeability of probes via tight junctions is based on molecular weight, along with properties such as geometry, flexibility, hydrophobicity, and charge.
To validate our in vitro results and assess a correlation with in vivo models, we monitored the oral pharmacokinetics and bioavailability of each molecular marker in a rat model exposed to various treatments associated with alcohol metabolism. To simulate the production of acetaldehyde in vivo, rats were treated with a combination of ethanol and the aldehyde dehydrogenase inhibitor disulfiram. Under these conditions we observed a marked increase in the systemic availability upon oral administration of low-but not highmolecular-weight probes (Fig. 3) . It should be noted that control experiments with ethanol and disulfiram alone did not have an effect on probe availability (Fig. 4) . Mannitol has been used as a standard probe in the assessment of junctional integrity (Swaan et al., 1994) . Thus, the animal data presented here correlate well with our in vitro results, indicating an acetaldehyde-induced permeability enhancement for low-molecular-weight molecules, most likely due to its disruptive effect on intestinal tight junctions. It has been Fig. 4 . In vivo AUC determinations in the in vivo rat model as analyzed by WinNonlin. Male Sprague-Dawley rats (n ϭ 6) were exposed to saline control (C), 33% ethanol (E), 100 mg/kg disulfiram (D), or ethanol/disulfiram (A) and given one of four molecular probes, [ suggested that acetaldehyde disrupts tight junctions via a tyrosine kinase-dependent mechanism (Atkinson and Rao, 2001) . Evidence exists for a dramatic reduction of the zonula occludens protein ZO-1 within tight junctions upon application of pathophysiologically relevant levels of acetaldehyde (ϳ650 M) (Rao, 1998; Atkinson and Rao, 2001) . Extending these in vitro observations to our studies, we conclude that acetaldehyde generated in vivo directly affects the intestinal tight junctional complex, thereby causing a temporary sizeand geometry-dependent increase in permeability. Overall, these results indicate that acetaldehyde, not ethanol, is responsible for the observed modulation of tight junctions both in vitro and in vivo.
To further assess the clinical relevance of the above observations, we determined the oral bioavailability of two drug molecules upon administration of saline (control), ethanol, disulfiram, or acetaldehyde (i.e., coadministered disulfiram/ ethanol). We selected the nonsteroidal anti-inflammatory drug naproxen as a representative control drug with a low molecular weight (252), high solubility at neutral to basic pH, and reportedly high permeability and almost complete (Ͼ95%) oral bioavailability. These features place naproxen in BCS class I (because pH influences naproxen solubility, low pH conditions would constitute a class II categorization). As expected, the addition of ethanol or production of acetaldehyde in the animal during drug administration had no significant effect on naproxen bioavailability (Fig. 5A) . The chemotherapeutic drug paclitaxel, on the other hand, is a relatively high-molecular-weight drug (854) that is insoluble in aqueous solution. It displays poor permeability characteristics partly because of its affinity for the efflux transporter P-glycoprotein, abundantly expressed along the GI tract. As a result, paclitaxel has low and variable bioavailability and is not traditionally given via oral routes of delivery. Owing to its poor permeability and solubility, it is a member of BCS class IV, which comprises drug molecules that are typically difficult to formulate. Thus, we used paclitaxel as a representative class IV drug (Varma and Panchagnula, 2005) to observe the effects of alcohol and it metabolites on the opening of tight junctions. After acetaldehyde production, plasma paclitaxel levels were significantly higher on oral administration compared with values for controls (saline, ethanol, and disulfiram) (Fig. 5B) , even though overall bioavailability remained low (Ͻ6%). It should be noted that disulfiram has been shown to be an inhibitor of P-glycoprotein in vitro (Loo et al., 2004) , probably by covalent modification of specific cysteine residues in both substrate and ATP-binding domains (Loo and Clarke, 2000) . However, metabolism of disulfiram, which is rapidly converted upon ingestion in the stomach (Johansson, 1992) , would make this result difficult to observe in vivo, especially because the studies were performed at disulfiram concentrations much higher than those achieved clinically. It is noteworthy that coadministration of disulfiram or ethanol with paclitaxel did not lead to increased paclitaxel plasma levels (Fig. 5B) , thereby excluding the possibility of an indirect effect of disulfiram or ethanol on P-glycoprotein activity that would influence intestinal paclitaxel permeability. Therefore, the increase in paclitaxel bioavailability observed here upon administration of disulfiram and ethanol cannot be attributed to inhibition of P-glycoprotein; however, an effect of in vivo-generated acetaldehyde on P-glycoprotein activity cannot be excluded. These results highlight the fact that perturbation of tight junctions can enhance the permeability of drug molecules and even overcome an opposing force created by efflux transporters.
These studies further demonstrate the pronounced effects of acetaldehyde on intestinal permeability and its impact on drug absorption in chronic alcoholics. Furthermore, data presented here add to mounting evidence that acetaldehyde is responsible for the loosening of tight junctions rather than ethanol. Although this series of experiments displays changes in functional assays, it is clear that continued examination of the mechanism by which acetaldehyde affects tight junctions, adherens junctions, proteins within these junctional complexes, or some combination thereof, is necessary. Overall, our data illustrate that modulation of the paracellular permeation pathway by acetaldehyde affects drug absorption and bioavailability, depending on drug size, geometry, and BCS classification. Rats were treated for 6 days via an oral bolus dose with saline control (Ⅺ), 5 g/kg ethanol (F), 100 mg/kg disulfiram (ࡗ), or 5 g/kg ethanol and 100 mg/kg disulfiram (f). Uptake of drug was measured as a percentage of the total starting dose using liquid scintillation. Each data point represents the mean Ϯ S.E.M. of at least six experiments from time 0 to 1440 min. Samples were analyzed for any statistically significant differences between groups using single-factor ANOVA. 
